ProShare Advisors
IMGN

ProShare Advisors’s Immunogen Inc IMGN Stock Holding History

ProShare Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-68,227
Closed -$2.02M – 2038
2023
Q4 		$2.02M Buy
68,227
+20,232
+42% +$403K 0.01% 650
2023
Q3 		$762K Sell
47,995
-764
-2% -$12.7K ﹤0.01% 774
2023
Q2 		$920K Buy
48,759
+8,184
+20% +$96.6K ﹤0.01% 746
2023
Q1 		$156K Sell
40,575
-5,308
-12% -$22.6K ﹤0.01% 1508
2022
Q4 		$228K Buy
45,883
+3,650
+9% +$19.8K ﹤0.01% 1407
2022
Q3 		$202K Buy
42,233
+939
+2% +$4.95K ﹤0.01% 1406
2022
Q2 		$185K Sell
41,294
-21,829
-35% -$94.8K ﹤0.01% 1495
2022
Q1 		$301K Sell
63,123
-8,627
-12% -$47.8K ﹤0.01% 1627
2021
Q4 		$533K Buy
71,750
+3,163
+5% +$19.7K ﹤0.01% 1392
2021
Q3 		$389K Sell
68,587
-18,029
-21% -$104K ﹤0.01% 1363
2021
Q2 		$571K Buy
86,616
+8,438
+11% +$58.9K ﹤0.01% 1439
2021
Q1 		$633K Buy
78,178
+8,282
+12% +$67.6K ﹤0.01% 1292
2020
Q4 		$451K Buy
69,896
+20,706
+42% +$121K ﹤0.01% 1332
2020
Q3 		$177K Sell
49,190
-2,028
-4% -$8.19K ﹤0.01% 1436
2020
Q2 		$236K Buy
51,218
+17,372
+51% +$73.9K ﹤0.01% 1367
2020
Q1 		$115K Sell
33,846
-18,185
-35% -$79.5K ﹤0.01% 1067
2019
Q4 		$266K Sell
52,031
-5,065
-9% -$17.2K ﹤0.01% 1418
2019
Q3 		$138K Sell
57,096
-1,754
-3% -$4.66K ﹤0.01% 1501
2019
Q2 		$128K Sell
58,850
-7,405
-11% -$17.5K ﹤0.01% 1511
2019
Q1 		$180K Buy
66,255
+595
+0.9% +$2.58K ﹤0.01% 1497
2018
Q4 		$315K Sell
65,660
-12,673
-16% -$76.9K ﹤0.01% 1122
2018
Q3 		$742K Buy
78,333
+5,543
+8% +$53.3K 0.01% 947
2018
Q2 		$708K Sell
72,790
-1,124
-2% -$11.8K ﹤0.01% 968
2018
Q1 		$778K Sell
73,914
-12,162
-14% -$120K 0.01% 927
2017
Q4 		$552K Buy
+86,076
New +$531K ﹤0.01% 1085
2017
Q1 		– Sell
-13,531
Closed -$28K – 1672
2016
Q4 		$28K Sell
13,531
-49,853
-79% -$100K ﹤0.01% 1729
2016
Q3 		$170K Sell
63,384
-11,738
-16% -$34.1K ﹤0.01% 1372
2016
Q2 		$231K Buy
75,122
+130
+0.2% +$815 ﹤0.01% 1339
2016
Q1 		$639K Sell
74,992
-7,506
-9% -$63.5K 0.01% 893
2015
Q4 		$1.12M Buy
82,498
+7,949
+11% +$97.8K 0.01% 693
2015
Q3 		$716K Sell
74,549
-5,190
-7% -$75.9K 0.01% 790
2015
Q2 		$1.15M Sell
79,739
-6,219
-7% -$68.3K 0.02% 716
2015
Q1 		$769K Buy
85,958
+10,621
+14% +$76.9K 0.01% 979
2014
Q4 		$460K Sell
75,337
-3,017
-4% -$27.6K 0.01% 1244
2014
Q3 		$830K Sell
78,354
-15,563
-17% -$176K 0.01% 1141
2014
Q2 		$1.11M Sell
93,917
-57,224
-38% -$718K 0.01% 1111
2014
Q1 		$2.26M Buy
151,141
+107,317
+245% +$1.69M 0.03% 671
2013
Q4 		$643K Sell
43,824
-39,535
-47% -$608K 0.01% 1044
2013
Q3 		$1.42M Buy
83,359
+13,037
+19% +$229K 0.03% 612
2013
Q2 		$1.17M Buy
+70,322
New +$1.14M 0.02% 750

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ProShare Advisors's IMGN Position: Q1 2024 in Review

ProShare Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 68,227 shares — an estimated $2.02M sold.

ProShare Advisors first reported a position in IMGN in Q2 2013 and held it in 40 quarters. The position peaked at $2.26M in Q1 2014. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • ProShare Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • ProShare Advisors sold 68,227 Immunogen Inc shares in Q1 2024, an estimated $2.02M.
  • ProShare Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 40 quarters.
  • ProShare Advisors's Immunogen Inc position peaked at $2.26M in Q1 2014.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on ProShare Advisors's 13F filing for Q1 2024, filed 8 May 2024.